Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas
1996

Comparing MIB-1 and S-phase Fraction in Breast Cancer

Sample size: 75 publication Evidence: moderate

Author Information

Author(s): PA Ellis, A Makris, SA Burton, J Titley, MG Ormerod, J Salter, TJ Powles, IE Smith, M Dowsett

Primary Institution: Royal Marsden NHS Trust; Institute of Cancer Research

Hypothesis

The study aims to compare the usefulness of MIB-1 with S-phase fraction (SPF) as a measure of proliferation in breast cancer.

Conclusion

MIB-1 immunostaining is an effective method for assessing proliferation in human breast carcinomas.

Supporting Evidence

  • MIB-1 staining showed a median score of 9% and SPF a median of 11.1%.
  • A close correlation was found between MIB-1 score and SPF (rho = 0.59, P < 0.0001).
  • The median MIB-1 score was significantly higher in aneuploid tumours compared to diploid tumours.

Takeaway

This study looked at how well a new test called MIB-1 works compared to a standard test for measuring how fast breast cancer cells are growing.

Methodology

The study involved staining tissue samples with MIB-1 and measuring S-phase fraction using flow cytometry.

Limitations

The correlation between MIB-1 and SPF was only significant in aneuploid tumours, and the study may not represent all breast cancer types.

Participant Demographics

75 post-menopausal patients with operable breast cancer, median ages 56 and 68 years for treatment and no treatment groups respectively.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI 0.48 - 0.76

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication